From Financial Modeling Prep: 2025-03-28 01:00:00

SeaStar Medical Holding Corporation, known as NASDAQ:ICU, released its financial results for Q4 and full year 2024, falling short of expectations. Despite launching QUELIMMUNE and expanding clinical trials, ICU reported an EPS of -$0.898 and revenue of $67,000. The negative P/E ratio, high P/S ratio, and liquidity issues signal financial challenges for the company.



Read more at Financial Modeling Prep:: SeaStar Medical Holding Corporation’s Financial Pe…